181 related articles for article (PubMed ID: 21380501)
1. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
[TBL] [Abstract][Full Text] [Related]
2. Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Lukas C; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Feb; 86(2):195-203. PubMed ID: 21892705
[TBL] [Abstract][Full Text] [Related]
3. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
6. Common predisposition alleles for moderately common cancers: bladder cancer.
Kiltie AE
Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
[TBL] [Abstract][Full Text] [Related]
7. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
9. The pursuit of genome-wide association studies: where are we now?
Ku CS; Loy EY; Pawitan Y; Chia KS
J Hum Genet; 2010 Apr; 55(4):195-206. PubMed ID: 20300123
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of HapMap SNPs.
Liu CT; Lin H; Lin H
Gene; 2012 Dec; 511(2):358-63. PubMed ID: 23041558
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of old and new genes for open-angle glaucoma.
Ramdas WD; van Koolwijk LM; Cree AJ; Janssens AC; Amin N; de Jong PT; Wolfs RC; Gibson J; Kirwan JF; Hofman A; Rivadeneira F; Oostra BA; Uitterlinden AG; Ennis S; Lotery AJ; Lemij HG; Klaver CC; Vingerling JR; Jansonius NM; van Duijn CM
Ophthalmology; 2011 Dec; 118(12):2389-97. PubMed ID: 21872936
[TBL] [Abstract][Full Text] [Related]
12. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.
Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J
Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636
[TBL] [Abstract][Full Text] [Related]
13. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
[TBL] [Abstract][Full Text] [Related]
14. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
[TBL] [Abstract][Full Text] [Related]
15. Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies.
Selinski S
Arch Toxicol; 2014 Jul; 88(7):1469-75. PubMed ID: 24912786
[No Abstract] [Full Text] [Related]
16. Bladder cancer course, four genetic high-risk variants, and histopathological findings.
Kadhum T; Selinski S; Blaszkewicz M; Reinders J; Roth E; Volkert F; Ovsiannikov D; Moormann O; Gerullis H; Barski D; Otto T; Höhne S; Hengstler JG; Golka K
EXCLI J; 2023; 22():867-879. PubMed ID: 37720238
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.
Koutros S; Kiemeney LA; Pal Choudhury P; Milne RL; Lopez de Maturana E; Ye Y; Joseph V; Florez-Vargas O; Dyrskjøt L; Figueroa J; Dutta D; Giles GG; Hildebrandt MAT; Offit K; Kogevinas M; Weiderpass E; McCullough ML; Freedman ND; Albanes D; Kooperberg C; Cortessis VK; Karagas MR; Johnson A; Schwenn MR; Baris D; Furberg H; Bajorin DF; Cussenot O; Cancel-Tassin G; Benhamou S; Kraft P; Porru S; Carta A; Bishop T; Southey MC; Matullo G; Fletcher T; Kumar R; Taylor JA; Lamy P; Prip F; Kalisz M; Weinstein SJ; Hengstler JG; Selinski S; Harland M; Teo M; Kiltie AE; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Schned A; Lenz P; Riboli E; Brennan P; Tjønneland A; Otto T; Ovsiannikov D; Volkert F; Vermeulen SH; Aben KK; Galesloot TE; Turman C; De Vivo I; Giovannucci E; Hunter DJ; Hohensee C; Hunt R; Patel AV; Huang WY; Thorleifsson G; Gago-Dominguez M; Amiano P; Golka K; Stern MC; ; Yan W; Liu J; Li SA; Katta S; Hutchinson A; Hicks B; Wheeler WA; Purdue MP; McGlynn KA; Kitahara CM; Haiman CA; Greene MH; Rafnar T; Chatterjee N; Chanock SJ; Wu X; Real FX; Silverman DT; Garcia-Closas M; Stefansson K; Prokunina-Olsson L; Malats N; Rothman N
Eur Urol; 2023 Jul; 84(1):127-137. PubMed ID: 37210288
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.
Batra J; O'Mara T; Patnala R; Lose F; Clements JA
Biol Chem; 2012 Dec; 393(12):1365-90. PubMed ID: 23667899
[TBL] [Abstract][Full Text] [Related]
19. Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population.
Ma Z; Hu Q; Chen Z; Tao S; Macnamara L; Kim ST; Tian L; Xu K; Ding Q; Zheng SL; Sun J; Xia G; Xu J
Mol Carcinog; 2013 Nov; 52(11):916-21. PubMed ID: 22711262
[TBL] [Abstract][Full Text] [Related]
20. Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.
Pattison JM; Posternak V; Cole MD
Mol Cancer Res; 2016 Nov; 14(11):1078-1086. PubMed ID: 27514407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
